NCT03710343View on ClinicalTrials.gov

Metformin for Motor and Cognitive Improvement in Children With Cerebral Palsy: A Feasibility Study

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

November 14, 2023

Primary Completion Date

April 11, 2025

Study Completion Date

April 24, 2025

Conditions
Cerebral Palsy
Interventions
DRUG

Metformin

Single case ABA study design. Phase B (intervention period) with metformin administered orally (or by gastrostomy tube) for 16 weeks.

Trial Locations (2)

M4G1R8

Holland Bloorview Kids Rehabilitation Hospital, Toronto

M5G 1X8

The Hospital for Sick Children, Toronto

All Listed Sponsors
collaborator

The Hospital for Sick Children

OTHER

lead

Holland Bloorview Kids Rehabilitation Hospital

OTHER

NCT03710343 - Metformin for Motor and Cognitive Improvement in Children With Cerebral Palsy: A Feasibility Study | Biotech Hunter | Biotech Hunter